Sweden · Delayed Price · Currency is SEK CellaVision AB Statistics
Total Valuation
CellaVision AB has a market cap or net worth of SEK 3.49 billion. The enterprise value is 3.28 billion.
| Market Cap | 3.49B |
| Enterprise Value | 3.28B |
Important Dates
The next confirmed earnings date is Friday, July 17, 2026.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | Apr 29, 2026 |
Share Statistics
CellaVision AB has 23.85 million shares outstanding.
| Current Share Class | 23.85M |
| Shares Outstanding | 23.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.24% |
| Owned by Institutions (%) | 62.72% |
| Float | 19.50M |
Valuation Ratios
The trailing PE ratio is 26.05 and the forward PE ratio is 23.41. CellaVision AB's PEG ratio is 2.04.
| PE Ratio | 26.05 |
| Forward PE | 23.41 |
| PS Ratio | 4.78 |
| PB Ratio | 3.82 |
| P/TBV Ratio | 4.90 |
| P/FCF Ratio | 19.27 |
| P/OCF Ratio | 17.33 |
| PEG Ratio | 2.04 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.91, with an EV/FCF ratio of 18.13.
| EV / Earnings | 24.50 |
| EV / Sales | 4.50 |
| EV / EBITDA | 15.91 |
| EV / EBIT | 18.93 |
| EV / FCF | 18.13 |
Financial Position
The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.80 |
| Quick Ratio | 2.82 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | 0.12 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 15.30% and return on invested capital (ROIC) is 19.08%.
| Return on Equity (ROE) | 15.30% |
| Return on Assets (ROA) | 9.95% |
| Return on Invested Capital (ROIC) | 19.08% |
| Return on Capital Employed (ROCE) | 17.16% |
| Weighted Average Cost of Capital (WACC) | 9.48% |
| Revenue Per Employee | 3.03M |
| Profits Per Employee | 556,290 |
| Employee Count | 241 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.94 |
Taxes
In the past 12 months, CellaVision AB has paid 36.18 million in taxes.
| Income Tax | 36.18M |
| Effective Tax Rate | 21.25% |
Stock Price Statistics
The stock price has decreased by -20.26% in the last 52 weeks. The beta is 0.96, so CellaVision AB's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -20.26% |
| 50-Day Moving Average | 128.91 |
| 200-Day Moving Average | 152.70 |
| Relative Strength Index (RSI) | 66.72 |
| Average Volume (20 Days) | 73,694 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellaVision AB had revenue of SEK 730.59 million and earned 134.07 million in profits. Earnings per share was 5.62.
| Revenue | 730.59M |
| Gross Profit | 496.66M |
| Operating Income | 173.45M |
| Pretax Income | 170.25M |
| Net Income | 134.07M |
| EBITDA | 194.13M |
| EBIT | 173.45M |
| Earnings Per Share (EPS) | 5.62 |
Balance Sheet
The company has 230.22 million in cash and 22.43 million in debt, with a net cash position of 207.79 million or 8.71 per share.
| Cash & Cash Equivalents | 230.22M |
| Total Debt | 22.43M |
| Net Cash | 207.79M |
| Net Cash Per Share | 8.71 |
| Equity (Book Value) | 914.25M |
| Book Value Per Share | 38.33 |
| Working Capital | 347.65M |
Cash Flow
In the last 12 months, operating cash flow was 201.54 million and capital expenditures -20.38 million, giving a free cash flow of 181.16 million.
| Operating Cash Flow | 201.54M |
| Capital Expenditures | -20.38M |
| Depreciation & Amortization | 20.67M |
| Net Borrowing | -15.52M |
| Free Cash Flow | 181.16M |
| FCF Per Share | 7.60 |
Margins
Gross margin is 67.98%, with operating and profit margins of 23.74% and 18.35%.
| Gross Margin | 67.98% |
| Operating Margin | 23.74% |
| Pretax Margin | 23.30% |
| Profit Margin | 18.35% |
| EBITDA Margin | 26.57% |
| EBIT Margin | 23.74% |
| FCF Margin | 24.80% |
Dividends & Yields
This stock pays an annual dividend of 2.75, which amounts to a dividend yield of 1.88%.
| Dividend Per Share | 2.75 |
| Dividend Yield | 1.88% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 44.48% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.88% |
| Earnings Yield | 3.84% |
| FCF Yield | 5.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for CellaVision AB is 177.75, which is 23.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 177.75 |
| Price Target Difference | 23.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 7.79% |
| EPS Growth Forecast (3Y) | 9.15% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |